The Food and Drug Administration Tuesday issued a circular to all manufacturers, asking them to stop production and sale of the 344 fixed-dose combination of drugs banned by the Ministry of Health and Family Welfare on March 12.
In the circular, direction for an immediate callback of drugs with the banned dose combination was also given across Maharashtra. Last week, the Drug Controller General of India announced a ban on several cough syrups which had a combination of codeine, affecting the sale of pharma giants such as Pfizer and Abbott. While Pfizer got an interim stay on the ban on Monday.
- FDA proposes to make licences mandatory for cosmetics retailers
- ‘Spurious cosmetics’ in branded bottles sold to parlours, salons: FDA
- Drug stores not officially told to keep stores open for 8 hours: Masaal
- After labelling fiasco,Hindustan Antibiotics restarts saline bottle production at Pimpri
- 4 booked for illegal sale of abortion pills
- All eyes on banned drugs
Harshdeep Kamble, FDA commissioner, said the ban has been enforced under section 26 A of Drug and Cosmetics Act, 1940. “But we do not know the count of manufacturers in Maharashtra who make drugs with the said banned combinations. The numbers could be very high,” he said.
Joint Commissioner B R Masal said the message has already been spread to local markets.